Welcome to National Black Church Initiative
and The Clinical Trial Portal of the American Clinical Health Disparities Commission
NBCI is ushering in a new era of broadened engagement of African American and Latino communities in clinical trials. Particularly given the unethical and illegal behaviors involved with the Tuskegee Experiment and the intentional absence or lack of critical information for the involved subjects by governmental officials, NBCI engages in a comprehensive approach to utilize important lessons learned from historic medical abuses for generating robust interest in substantially improving clinical trial participation.
The goal of the NBCI Interactive Clinical Trials Portal is to improve the health outcomes of the African American and Latino communities by ensuring their awareness of critical features, benefits, and challenges of the clinical trials. This website offers scientific facts and data-driven information that may positively influence the viewpoints and feelings African Americans and Latinos may have regarding their participation in clinical trials. This website also attempts to demystify any misconceptions about clinical trials that African Americans and/or Latinos might have.
Faith and Medicine l Primary Care
The National Black Church Initiative (NBCI), a coalition of 150,000 African-American and Latino churches with a population of 27.7 million, focuses on eradicating racial disparities in healthcare, clinical trials, technology, education, housing, and the environment. NBCI advocates for drug therapies to improve the overall health and well-being of African Americans and Latinos.
Therapeutic Areas of Interest to the African American and Latino Communities: NBCI Clinical Research Approach
There are nine (9) pillars of NBCI Clinical Research Approaches to be used:
- Cardiovascular Diseases
- Cancer: (Liver/Kidney/Lung ...etc)
- Diabetes
- Blood Diseases
- Genetic Disease ( Sickle Cell)
- Mental health
- Acess to Care/ lifestyles/ Selfcare
- Collection of Health Data
- Rare Diseases
FDA to Require Diversity Plan for Clinical Trials
US regulatory agency is making a ‘big change’ to increase the number of participants from traditionally under-represented groups in drug testing. This will include African Americans, Latinos, and other minoritized communities to be involved in clinical trials. The US Food and Drug Administration (FDA) will soon require researchers and companies seeking approval for late-stage clinical trials to submit a plan for ensuring diversity among trial participants.
Black communities endured wave of excess deaths in past 2 decades, studies find
The Washington Post reveals that the loss of life came at a staggering cost, medically and economically
Read More
Study: Black Americans Live Longer When There Are More Black Doctors In The County
Time and again, it has been stressed that representation matters. Studies have shown it matters in education. It matters in the judicial system. And a new study shows it matters in the medical field.
Read More